Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents

MLA

Dario Ferrero, et al. “Survival Improvement of Poor-Prognosis AML/MDS Patients by Maintenance Treatment with Low-Dose Chemotherapy and Differentiating Agents.” Annals of Hematology, vol. 93, Apr. 2014, pp. 1391–400. EBSCOhost, https://doi.org/10.1007/s00277-014-2047-7.

APA

Dario Ferrero, Mario Boccadoro, Ernesta Audisio, Filippo Marmont, Elena Crisà, Tiziana Gatti, Valentina Giai, Roberto Passera, Chiara Frairia, Ludovica Riera, Benedetto Bruno, & Moreno Festuccia. (2014). Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. Annals of Hematology, 93, 1391–1400. https://doi.org/10.1007/s00277-014-2047-7

Chicago

Dario Ferrero, Mario Boccadoro, Ernesta Audisio, Filippo Marmont, Elena Crisà, Tiziana Gatti, Valentina Giai, et al. 2014. “Survival Improvement of Poor-Prognosis AML/MDS Patients by Maintenance Treatment with Low-Dose Chemotherapy and Differentiating Agents.” Annals of Hematology 93 (April): 1391–1400. doi:10.1007/s00277-014-2047-7.